Table 3.
Use of Medications according to the C-Reactive Protein Level at Diagnosis
| Variable | CRP >20 (n=373) | CRP ≤20 (n=332) | p-value |
|---|---|---|---|
| Use of medications | |||
| 5-ASA | 368 (98.7) | 309 (93.1) | <0.001 |
| Antibiotics | 239 (64.1) | 153 (46.1) | <0.001 |
| Budesonide | 42 (11.3) | 32 (9.6) | 0.494 |
| Corticosteroid | 263 (70.5) | 164 (49.7) | <0.001 |
| Azathioprine | 281 (75.3) | 194 (58.4) | <0.001 |
| MTX | 4 (1.1) | 6 (1.8) | 0.407 |
| Infliximab | 102 (27.4) | 66 (19.9) | 0.023 |
| Adalimumab | 21 (5.6) | 15 (4.5) | 0.516 |
| TNF blocker | 111 (29.8) | 76 (22.9) | 0.042 |
| TPN | 77 (20.6) | 59 (17.8) | 0.796 |
| Time to use of azathioprine, mo | 28.8±34.0 | 28.6±31.3 | 0.950 |
| Time to use of TNF blockers, mo | 52.2±41.1 | 61.8±43.1 | 0.114 |
Data are presented as number (%) or mean±SD.
CRP, C-reactive protein; ASA, aminosalicylic acid; MTX, methotrexate; TNF, tumor necrosis factor; TPN, total parenteral nutrition.